The excellent bactericidal action against almost all gram-negative bacilli including poly-resistant strains. Effective therapy of severe infection caused P. aeruginosa and Acinetobacter
Main
ABOLmed is the first Russian pharmaceutical company met all the substantial criteria set out in the EudraLex «The Rules Governing Medicinal Products in the European Union, Vol. 4 EU Guideline to GMP, Medicinal Products for Humans and Veterinary Use»
ABOLmed LLC is one of the Russian leading companies specializing in the development, manufacture and sale of first-class generic pharmaceuticals.
"ABOLmed" LLC was founded in April 1998 in Moscow, and in a half a year it has developed the production of cephalosporins family antibiotics for injection at newly established pharm manufactory in Vidnoe near Moscow (with 10 million vials annual production capacity).
The main priorities of "ABOLmed" Ltd Company activity are as follows: the permanent application of the advanced technologies; the guarantees of high expansion of the labour productivity and of excellent product quality; the introduction of new pharmaceuticals in the Russian market; the investment of research investigations on the creation of new original drugs; and the raising of the level of general practitioners skill.
In December 2004, the "ABOLmed" Ltd Company opened the first order of the new pharmaceutical factory in Novosibirsk, which had been built for four years (annual production capacity - 50 million vials). This factory is in full compliance with GMP standards for pharmaceutical manufacturing firms.
